ALLMedicine™ Robotic Surgery Center
Research & Reviews 272 results
https://doi.org/10.1093/jnci/djac130
Journal of the National Cancer Institute; Hardman JC, Holsinger FC et. al.
Aug 10th, 2022 - Transoral robotic surgery (TORS) is an emerging minimally invasive surgical treatment for residual, recurrent, and new primary head and neck cancers in previously irradiated fields, with limited evidence for its oncological effectiveness. A retros...
https://doi.org/10.1245/s10434-022-12371-w
Annals of Surgical Oncology; Garas G, Roland NJ et. al.
Aug 9th, 2022 - ASO Visual Abstract: Novel Strategies for Managing Retropharyngeal Lymph Node Metastases in Head and Neck and Thyroid Cancer with TransOral Robotic Surgery (TORS).|2022|Garas G,Roland NJ,Lancaster J,Zammit M,Manon VA,|
https://doi.org/10.1007/s11701-022-01448-z
Journal of Robotic Surgery; Holcomb AJ, Kammer R et. al.
Aug 8th, 2022 - To understand perioperative practices for transoral robotic surgery (TORS) among academic medical centers. An electronic cross-sectional survey was distributed to fellows and program directors participating in 49 American Head and Neck Society fel...
https://doi.org/10.1007/s00464-022-09442-0
Surgical Endoscopy; Zhang MX, Chi SQ et. al.
Aug 2nd, 2022 - Most commonly, cyst excision and Roux-en-Y hepaticojejunostomy reconstruction are the optimal treatment for choledochal cysts (CC). Robotic surgery (RS) is being conducted with increasing frequency to treat CC. It is unclear whether RS can overcom...
https://doi.org/10.1245/s10434-022-12297-3
Annals of Surgical Oncology; Garas G
Jul 27th, 2022 - ASO Author Reflections: Novel Treatment De-escalation Strategies for Retropharyngeal Metastatic Disease in Head and Neck and Thyroid Cancer with Transoral Robotic Surgery (TORS).|2022|Garas G,|
News 7 results
https://www.medscape.com/viewarticle/961779
Oct 29th, 2021 - NEW YORK (Reuters Health) - Among carefully selected patients with HPV-positive oropharynx squamous cell carcinoma (OPSCC) undergoing primary transoral robotic surgery (TORS), it is likely that 25% will need radiochemotherapy afterward, a single-c...
https://www.staging.medscape.com/viewarticle/940648
Nov 10th, 2020 - NEW YORK (Reuters Health) - In selected older patients with human papillomavirus-associated oropharyngeal cancer, transoral robotic surgery (TORS) can boost survival and avert the need for chemotherapy, researchers found in a single-center study. ...
https://www.medscape.com/viewarticle/940648
Nov 10th, 2020 - NEW YORK (Reuters Health) - In selected older patients with human papillomavirus-associated oropharyngeal cancer, transoral robotic surgery (TORS) can boost survival and avert the need for chemotherapy, researchers found in a single-center study. ...
https://www.medscape.com/viewarticle/936219
Aug 24th, 2020 - Transoral robotic surgery (TORS) was associated with better survival and improved surgical outcomes in comparison with nonrobotic surgery in patients with early-stage oropharyngeal cancer in a retrospective analysis of nearly 10,000 cases. The sur...
https://www.medscape.com/viewarticle/914286
Jun 12th, 2019 - CHICAGO — For patients with oropharyngeal squamous cell cancer (OPSCC), opting for radiation therapy rather than surgery may result in better swallowing outcomes, which in turn may mean a better quality of life, according to new findings. The find...